33599317|t|Porphyromonas gingivalis lipopolysaccharide induces interleukin-6 and c-c motif chemokine ligand 2 expression in cultured hCMEC/D3 human brain microvascular endothelial cells.
33599317|a|OBJECTIVE: This paper describes the effect of Porphyromonas gingivalis (P gingivalis) lipopolysaccharide (LPS) on the expression of interleukin-6 (IL-6) and C-C motif chemokine ligand 2 (CCL2) in cultured hCMEC/D3 human brain microvascular endothelial cells. BACKGROUND: P gingivalis is one of the important pathogens in periodontitis, and periodontitis is a risk factor for brain disorders including cerebrovascular diseases and Alzheimer's disease. However, the mechanisms underlying the pathogenesis of P gingivalis-mediated brain diseases are incompletely understood. Effects of P gingivalis LPS on brain endothelial cells are not known well. METHODS: The hCMEC/D3 human brain microvascular endothelial cells were cultured and treated with P gingivalis LPS. The expression of IL-6 and CCL2 mRNA and protein was examined using quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Effect of inhibitors of Toll-like receptor (TLR) 2, TLR4, nuclear factor-kappaB (NF-kappaB), p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) was also investigated. Phosphorylation of NF-kappaB p65, p38 MAPK and JNK was examined using Western blotting. RESULTS: P gingivalis LPS-induced mRNA and protein expression of IL-6 and CCL2 in hCMEC/D3 cells in a concentration-dependent manner at the concentration of 0.5-50 microg/mL. Maximal mRNA expression of IL-6 and CCL2 was found 2 and 4 hours after stimulation, respectively. Induction of IL-6 and CCL2 by P gingivalis LPS was almost completely inhibited by pretreatment of cells with TLR4 inhibitor but not by TLR2 inhibitor. Treatment of cells with P gingivalis LPS for up to 2 hours induced phosphorylation of NF-kappaB p65, p38 MAPK and JNK. IL-6 induction was decreased by pretreatment of cells with NF-kappaB inhibitor SN50 or p38 MAPK inhibitor SB203580, while CCL2 induction was reduced by SN50 or JNK inhibitor SP600125. CONCLUSIONS: IL-6 and CCL2 produced upon P gingivalis LPS stimulation may contribute to the inflammatory reactions in brain endothelial cells and subsequent neurological disorders such as cerebrovascular and Alzheimer's diseases.
33599317	0	24	Porphyromonas gingivalis	Species	837
33599317	25	43	lipopolysaccharide	Chemical	MESH:D008070
33599317	52	65	interleukin-6	Gene	3569
33599317	70	98	c-c motif chemokine ligand 2	Gene	6347
33599317	122	130	hCMEC/D3	CellLine	CVCL:U985
33599317	131	136	human	Species	9606
33599317	222	246	Porphyromonas gingivalis	Species	837
33599317	248	260	P gingivalis	Species	837
33599317	262	280	lipopolysaccharide	Chemical	MESH:D008070
33599317	282	285	LPS	Chemical	MESH:D008070
33599317	308	321	interleukin-6	Gene	3569
33599317	323	327	IL-6	Gene	3569
33599317	333	361	C-C motif chemokine ligand 2	Gene	6347
33599317	363	367	CCL2	Gene	6347
33599317	381	389	hCMEC/D3	CellLine	CVCL:U985
33599317	390	395	human	Species	9606
33599317	447	459	P gingivalis	Species	837
33599317	497	510	periodontitis	Disease	MESH:D010518
33599317	516	529	periodontitis	Disease	MESH:D010518
33599317	551	566	brain disorders	Disease	MESH:D001927
33599317	577	601	cerebrovascular diseases	Disease	MESH:D002561
33599317	606	625	Alzheimer's disease	Disease	MESH:D000544
33599317	682	694	P gingivalis	Species	837
33599317	704	718	brain diseases	Disease	MESH:D001927
33599317	759	771	P gingivalis	Species	837
33599317	772	775	LPS	Chemical	MESH:D008070
33599317	836	844	hCMEC/D3	CellLine	CVCL:U985
33599317	845	850	human	Species	9606
33599317	920	932	P gingivalis	Species	837
33599317	933	936	LPS	Chemical	MESH:D008070
33599317	956	960	IL-6	Gene	3569
33599317	965	969	CCL2	Gene	6347
33599317	1144	1170	Toll-like receptor (TLR) 2	Gene	7097
33599317	1172	1176	TLR4	Gene	7099
33599317	1178	1199	nuclear factor-kappaB	Gene	4790
33599317	1201	1210	NF-kappaB	Gene	4790
33599317	1213	1249	p38 mitogen-activated protein kinase	Gene	1432
33599317	1261	1284	c-Jun N-terminal kinase	Gene	5599
33599317	1286	1289	JNK	Gene	5599
33599317	1333	1346	NF-kappaB p65	Gene	5970
33599317	1361	1364	JNK	Gene	5599
33599317	1411	1423	P gingivalis	Species	837
33599317	1424	1427	LPS	Chemical	MESH:D008070
33599317	1467	1471	IL-6	Gene	3569
33599317	1476	1480	CCL2	Gene	6347
33599317	1484	1492	hCMEC/D3	CellLine	CVCL:U985
33599317	1604	1608	IL-6	Gene	3569
33599317	1613	1617	CCL2	Gene	6347
33599317	1688	1692	IL-6	Gene	3569
33599317	1697	1701	CCL2	Gene	6347
33599317	1705	1717	P gingivalis	Species	837
33599317	1718	1721	LPS	Chemical	MESH:D008070
33599317	1784	1788	TLR4	Gene	7099
33599317	1810	1814	TLR2	Gene	7097
33599317	1850	1862	P gingivalis	Species	837
33599317	1863	1866	LPS	Chemical	MESH:D008070
33599317	1912	1925	NF-kappaB p65	Gene	5970
33599317	1940	1943	JNK	Gene	5599
33599317	1945	1949	IL-6	Gene	3569
33599317	2004	2013	NF-kappaB	Gene	4790
33599317	2024	2028	SN50	Chemical	-
33599317	2051	2059	SB203580	Chemical	MESH:C093642
33599317	2067	2071	CCL2	Gene	6347
33599317	2097	2101	SN50	Chemical	-
33599317	2105	2108	JNK	Gene	5599
33599317	2119	2127	SP600125	Chemical	MESH:C432165
33599317	2142	2146	IL-6	Gene	3569
33599317	2151	2155	CCL2	Gene	6347
33599317	2170	2182	P gingivalis	Species	837
33599317	2183	2186	LPS	Chemical	MESH:D008070
33599317	2221	2233	inflammatory	Disease	MESH:D007249
33599317	2286	2308	neurological disorders	Disease	MESH:D009461
33599317	2317	2357	cerebrovascular and Alzheimer's diseases	Disease	MESH:D000544
33599317	Positive_Correlation	MESH:D008070	5599
33599317	Positive_Correlation	MESH:D008070	3569
33599317	Association	3569	7099
33599317	Positive_Correlation	MESH:D008070	5970
33599317	Association	MESH:D008070	7099
33599317	Negative_Correlation	MESH:C093642	3569
33599317	Association	6347	7099
33599317	Negative_Correlation	MESH:C432165	5599
33599317	Positive_Correlation	MESH:D008070	6347

